Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study
Launched by HAUKELAND UNIVERSITY HOSPITAL · Jul 5, 2018
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Screening of cognitive and behavioral impairment is a distinct recommendation in ALS-specific health-care. Thus, a rapid screening tool valid for use in Norway is urgent. However, cognitive assessment for patients with ALS can be difficult due to the complexity of cognitive impairment, as well as motor challenges with writing, drawing and speaking. Therefore, only ALS-specific, multi domain screening instruments with integrated behavioral sections should be used. Internationally, the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS), is recommended for the purpo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • voluntary informed consent
- • native Norwegian speaker
- • aged between 35 and 85 years old (only for Controls)
- Exclusion Criteria:
- • great difficulties in writing og Reading
- • comorbid Medical history
- • neurological disorders others than ALS
- • psychiatric history of importance to cognitive function
About Haukeland University Hospital
Haukeland University Hospital, located in Bergen, Norway, is a leading academic medical center renowned for its commitment to innovative research and high-quality patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical fields to facilitate cutting-edge clinical studies that aim to advance healthcare outcomes. With a multidisciplinary team of healthcare professionals and researchers, Haukeland University Hospital fosters collaboration and knowledge exchange, ensuring that trials are conducted with the highest standards of ethics, safety, and scientific rigor. Its strategic focus on translational research enhances the bridge between laboratory discoveries and real-world applications, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, , Norway
Patients applied
Trial Officials
Tina Taule, PhD
Principal Investigator
Haukeland University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials